
Bloomberg Businessweek Weekend - August 1st, 2025
Bloomberg Businessweek
00:00
AstraZeneca's Strategic Investment and Innovation Landscape
This chapter discusses AstraZeneca's recent financial success, emphasizing a $50 billion investment in U.S. production and research by 2030. The conversation explores the competitive pressures from China's pharmaceutical advancements and the need for U.S. leadership in biosciences. Additionally, it highlights significant trends and innovations in drug development aimed at addressing critical health issues.
Transcript
Play full episode